AstraZeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction

AstraZeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction  Barron's

Summary aggregated from Barron's's public RSS feed. The full reporting belongs to Barron's — please read it on their site.